Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Relay Therapeutics Inc (RLAY)

Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Relay Therapeutics Inc 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 USA

www.relaytx.com Employees: 261 P: 617-370-8837

Sector:

Medical

Description:

Relay Therapeutics Inc. is a clinical-stage precision medicines company. It focuses on enhancing small molecule therapeutic discovery in targeted oncology. The company's product pipeline consist RLY-1971, RLY-4008 and RLY-PI3K1047 which are in clinical stage. Relay Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 1,507,901
Enterprise Value, $K 1,383,611
Shares Outstanding, K 173,322
Float, K 164,881
% Float 95.13%
Short Interest, K 24,025
Short Float 13.86%
Days to Cover 9.52
Short Volume Ratio 0.64
% of Insider Shareholders 4.87%
% of Institutional Shareholders 96.98%

Financials:

Annual Sales, $ 10,010 K
Annual Net Income, $ -337,710 K
Last Quarter Sales, $ 680 K
Last Quarter Net Income, $ -70,380 K
EBIT, $ -343,070 K
EBITDA, $ -349,920 K

Growth:

1-Year Return 112.71%
3-Year Return -49.00%
5-Year Return -78.92%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.43 on 11/06/25
Next Earnings Date 02/25/26 [AMC]
Earnings Per Share ttm -1.95
EPS Growth vs. Prev Qtr -4.88%
EPS Growth vs. Prev Year 31.75%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RLAY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -42.94%
Return-on-Assets % -38.78%
Profit Margin % -3,373.73%
Debt/Equity 0.00
Price/Sales 177.13
Price/Cash Flow N/A
Price/Book 2.51
Book Value/Share 3.88
Interest Coverage -4.33
60-Month Beta 1.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar